• OUR DATA
  • BUY REPORTS & LISTS
  • OUR BLOG
 

Download a FREE copy of B2B Selling for Dummies Now!



Janssen Pharmaceuticals Inc Revenue and Financial Data

Janssen Pharmaceuticals offers a wide range of therapeutics, including products for attention deficit hyperactivity disorder (ADHD), general medicine (acid reflux disease, infectious diseases), mental health (bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, migraine prevention and treatment), pain management, and women’s health. A US-based arm of Johnson & Johnson's global pharmaceuticals segment, the company's offerings include Risperdal for schizophrenia, anti-infective Levaquin, ADHD drug Concerta, pain medicine Nucynta, and contraceptive Ortho Evra.

Financials Information for Janssen Pharmaceuticals Inc

Track this company’s financial condition.
View Company Report
Request Your Free Trial

  • Income Statement
  • Cash Flow
  • Balance Sheet
  • Credit Rating
Income Statement
Revenue $197.6
Gross Profit $0.0
Operating Income $0.0
Net Income $0.0
Diluted EPS $0.0
Cash Flow (mil)
Cash at the beginning of the year $
Net Operating Cash $
Net Investing Cash $
Net Financing Cash $
Net Change in Cash $
Cash at end of the year $
Capital Expenditure $
Assets (mil)
Current Assets
Cash $
Net Receivables $
Inventories $
Other Income Assets $
Asset Summary
Total Current Assets $
Net Fixed Assets $
Other Noncurrent Assets $
Total Assets $
Liabilities (mil)
Current Liabilities
Accounts Payable $
Short Term Debt $
Other Current Liabilities $
Liability Summary
Total Current Liabilities $
Long Term Debt $
Other Noncurrent Liabilities $
Total Liabilities $
Stakeholder's Equity (mil)
Equity
Preferred Stock Equity $
Common Stock Equity $
Equity Summary
Total Equity $
Shares Outstanding

Credit Rating

Medium
These businesses have a moderate projected risk of delinquency and a moderate to low risk of failure.

Need to go deeper? No problem.

  • Save time with complex financial data at your fingertips
  • Access financial statements, SEC filings, earnings estimates, and more
  • Call (866) 473-3932 to talk to a Business Information Consultant